Physician profile
Sarah E Weaver
NPI 1306289582
$988.58
in general payments reported to CMS, 2019-2025
7 companies · $543 in 2025
The $543 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.78 · 2023: $257 · 2024: $176 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710 · Entertainment: $248 · Education: $18.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.61 |
| Entertainment | $248.15 |
| Education | $18.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $266.53 | 2023-2025 | Jada System, Nexplanon |
| Fisher Scientific Company L.L.C. | $266.19 | 2025 | Procalcitonin |
| Hologic Sales and Service, LLC | $217.44 | 2023 | Novasure, Omni Hysteroscope, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $112.00 | 2024 | Veozah |
| Laborie Medical Technologies Corp. | $99.02 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.62 | 2023 | |
| Coopersurgical, INC. | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.